Table 2.
Information of 25 pathways.
| ID | Description | P. adjust | Count |
|---|---|---|---|
| hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 4.29750564649423e-15 | 27 |
| hsa04915 | Estrogen signaling pathway | 4.29750564649423e-15 | 31 |
| hsa05205 | Proteoglycans in cancer | 7.02978144058047e-12 | 33 |
| hsa05418 | Fluid shear stress and atherosclerosis | 3.50540676797616e-09 | 24 |
| hsa04928 | Parathyroid hormone synthesis, secretion, and action | 3.50540676797616e-09 | 21 |
| hsa05224 | Breast cancer | 8.65129662473866e-09 | 24 |
| hsa04934 | Cushing syndrome | 2.25061036469472e-08 | 24 |
| hsa05215 | Prostate cancer | 2.25061036469472e-08 | 19 |
| hsa04024 | cAMP signaling pathway | 4.25537215261066e-08 | 28 |
| hsa05032 | Morphine addiction | 4.35290458036493e-08 | 18 |
| hsa05143 | African trypanosomiasis | 5.25038311520481e-08 | 12 |
| hsa04912 | GnRH signaling pathway | 5.25038311520481e-08 | 18 |
| hsa01522 | Endocrine resistance | 1.16942061208876e-07 | 18 |
| hsa05226 | Gastric cancer | 1.53049773606446e-07 | 22 |
| hsa04080 | Neuroactive ligand-receptor interaction | 3.92997114777747e-07 | 34 |
| hsa04010 | MAPK signaling pathway | 4.75554213381079e-07 | 31 |
| hsa04020 | Calcium signaling pathway | 8.10557748077706e-07 | 24 |
| hsa04921 | Oxytocin signaling pathway | 1.09530352609987e-06 | 21 |
| hsa05144 | Malaria | 1.3497422679709e-06 | 12 |
| hsa04659 | Th17 cell differentiation | 1.90497387620456e-06 | 17 |
| hsa04066 | HIF-1 signaling pathway | 2.39525818923615e-06 | 17 |
| hsa05210 | Colorectal cancer | 2.67545458381123e-06 | 15 |
| hsa04929 | GnRH secretion | 2.67545458381123e-06 | 13 |
| hsa04927 | Cortisol synthesis and secretion | 3.01425725456316e-06 | 13 |
| hsa04668 | TNF signaling pathway | 3.01425725456316e-06 | 17 |